Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis

Gene Therapy volume 30, pages 51–63 (2023)Cite this article

Subjects

Abstract

Genetic association between E3 ubiquitin ligase SMURF2 and colorectal cancer (CRC) has been identified, while the mechanism remains undefined. Tumor-promoting gene YY1 represents a downstream factor of SMURF2. The study was designed to evaluate the effect of SMURF2 on the malignant phenotypes of CRC cells and the underlying mechanism. The expression pattern of SMURF2 and YY1 in CRC clinical tissues and cells was characterized by immunohistochemistry (IHC) and Western blot. Gain- and loss-of-function experiments were conducted to assess the effect of SMURF2 and YY1 on the behaviors of CRC cells. After bioinformatics analysis, the relationship between YY1 and SENP1 as well as between SENP1 and c-myc was determined by luciferase reporter and ChIP assays. Rescue experiments were performed to show their involvement during CRC progression. Finally, in vivo models of tumor growth were established for validation. SMURF2 was lowly expressed and YY1 was highly expressed in CRC tissues and cells. YY1 overexpression resulted in promotion of CRC cell proliferation, migration, and invasion, which could be reversed by SMURF2. Furthermore, SMURF2 could induce ubiquitination-mediated degradation of YY1, which bound to the SENP1 promoter and upregulated SENP1 expression, leading to enhancement of c-myc expression. The in vivo data revealed the suppressive role of SMURF2 gain-of-function in tumor growth through downregulation of YY1, SENP1, or c-myc. Altogether, our data demonstrate the antitumor activity of SMURF2 in CRC and the anti-tumor mechanism associated with degradation of YY1 and downregulation of SENP1/c-myc.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: YY1 is highly expressed in CRC tissues and cells.
Fig. 2: Silencing or knockdown of YY1 impedes the proliferation, migration, and invasion of CRC cells and stimulates their apoptosis.
Fig. 3: SMURF2 is poorly expressed in CRC tissues and cells, and it promotes the ubiquitination and degradation of YY1.
Fig. 4: Overexpression of YY1 reverts the inhibitory effect of SMURF2 on the proliferation, migration, and invasion of CRC cells as well as the promoting effect of SMURF2 on cells apoptosis.
Fig. 5: YY1 binds to the promoter of SENP1 and elevates its expression, thus reducing the SUMOylation level of c-myc and increasing the expression of c-myc.
Fig. 6: SENP1 or c-myc silencing weakens the promoting effect of YY1 overexpression on the proliferation, migration, and invasion of CRC cells.
Fig. 7: SMURF2 degrades YY1 through ubiquitination and suppresses the SENP1/c-myc axis, thus inhibiting tumorigenicity of the CRC cells in vivo.
Fig. 8: The mechanism graph of the regulatory network and function of SMURF2 in CRC.

Similar content being viewed by others

Availability of data and materials

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  2. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–91.

    Article  PubMed  Google Scholar 

  3. Brody H. Colorectal cancer. Nature. 2015;521:S1.

    Article  CAS  PubMed  Google Scholar 

  4. Han G, Wei Z, Cui H, Zhang W, Wei X, Lu Z, et al. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer. Exp Cell Res. 2018;367:216–21.

    Article  CAS  PubMed  Google Scholar 

  5. Perea J, Cano JM, Rueda D, Garcia JL, Inglada L, Osorio I, et al. Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore. Am J Cancer Res. 2015;5:2308–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Bi H, Tian T, Zhu L, Zhou H, Hu H, Liu Y, et al. Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer. Sci Rep. 2016;6:29869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shen J, Yu Z, Li N. The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/beta-catenin pathway via ubiquitination of Axin1. Biochem Biophys Res Commun. 2018;503:991–7.

    Article  CAS  PubMed  Google Scholar 

  8. Koganti P, Levy-Cohen G, Blank M. Smurfs in protein homeostasis, signaling, and cancer. Front Oncol. 2018;8:295.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jeong HM, Lee SH, Yum J, Yeo CY, Lee KY. Smurf2 regulates the degradation of YY1. Biochim Biophys Acta. 2014;1843:2005–11.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, et al. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene. 2013;32:5078–88.

    Article  CAS  PubMed  Google Scholar 

  11. Tang W, Zhou W, Xiang L, Wu X, Zhang P, Wang J, et al. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer. Nat Commun. 2019;10:663.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wu T, Donohoe ME. Yy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization. J Biomed Sci. 2019;26:79.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhou GQ, Han F, Shi ZL, Yu L, Li XF, Yu C, et al. miR-133a-3p targets SUMO-specific protease 1 to inhibit cell proliferation and cell cycle progress in colorectal cancer. Oncol Res. 2018;26:795–800.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov. 2015;5:1024–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sun XX, Chen Y, Su Y, Wang X, Chauhan KM, Liang J, et al. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc. Proc Natl Acad Sci USA. 2018;115:10983–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Elbadawy M, Usui T, Yamawaki H, Sasaki K. Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer. Int J Mol Sci. 2019;20:2340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang H, Cao F, Li X, Miao H, Jifu E, Xing J, et al. miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells. BMC Cancer. 2015;15:748.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wei Y, Zhao W, Huang Y, Yu Q, Zhu S, Wang S, et al. A comparative study of noninvasive hypoxia imaging with 18F-fluoroerythronitroimidazole and 18F-fluoromisonidazole PET/CT in patients with lung cancer. PLoS One. 2016;11:e0157606.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lu H, Wang X, Li T, Urvalek AM, Yu L, Li J, et al. Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein. J Biol Chem. 2011;286:20335–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lu H, Hu L, Li T, Lahiri S, Shen C, Wason MS, et al. A novel role of Kruppel-like factor 8 in DNA repair in breast cancer cells. J Biol Chem. 2012;287:43720–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lahiri SK, Lu H, Mukherjee D, Yu L, Zhao J. ERK2 phosphorylates Kruppel-like factor 8 protein at serine 48 to maintain its stability. Am J Cancer Res. 2016;6:910–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Li Y, Yang D, Tian N, Zhang P, Zhu Y, Meng J, et al. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation. J Biol Chem. 2019;294:14745–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ramkumar C, Cui H, Kong Y, Jones SN, Gerstein RM, Zhang H. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun. 2013;4:2598.

    Article  PubMed  Google Scholar 

  24. Bray C, Bell LN, Liang H, Collins D, Yale SH. Colorectal cancer screening. WMJ. 2017;116:27–33.

    PubMed  Google Scholar 

  25. Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol. 2017;23:5086–96.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Muller MF, Ibrahim AE, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Arch. 2016;469:125–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wottrich S, Kaufhold S, Chrysos E, Zoras O, Baritaki S, Bonavida B. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer. Drug Resist Updat. 2017;30:28–38.

    Article  PubMed  Google Scholar 

  28. Yu L, Dong L, Wang Y, Liu L, Long H, Li H, et al. Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression. Cancer Lett. 2019;448:40–51.

    Article  CAS  PubMed  Google Scholar 

  29. Klupp F, Giese C, Halama N, Franz C, Lasitschka F, Warth A, et al. E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer. Cancer Manag Res. 2019;11:1795–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: implications for diagnosis and therapy. Oncol Lett. 2018;16:9–18.

    PubMed  PubMed Central  Google Scholar 

  31. Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18:197.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wang Q, Zhou Y, Rychahou P, Harris JW, Zaytseva YY, Liu J, et al. Deptor is a novel target of Wnt/beta-Catenin/c-Myc and contributes to colorectal cancer cell growth. Cancer Res. 2018;78:3163–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Emanuelli A, Manikoth Ayyathan D, Koganti P, Shah PA, Apel-Sarid L, Paolini B, et al. Altered expression and localization of tumor suppressive E3 ubiquitin ligase SMURF2 in human prostate and breast cancer. Cancers. 2019;11:556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Wang W, Li D, Sui G. YY1 is an inducer of cancer metastasis. Crit Rev Oncog. 2017;22:1–11.

    Article  PubMed  Google Scholar 

  35. Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J, Yeh ET. SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 2017;8:17651–64.

    Article  PubMed  Google Scholar 

  36. Yin S, Cheryan VT, Xu L, Rishi AK, Reddy KB. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS One. 2017;12:e0183578.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge and appreciate our colleagues for their valuable suggestions and technical assistance for this study.

Author information

Authors and Affiliations

  1. Anorectal Department, Linyi People’s Hospital, Linyi, 276003, PR China

    Qianfu Gao, Shanchao Wang & Zeyan Zhang

Authors
  1. Qianfu Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shanchao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zeyan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed research: QFG; Performed experiments: QFG, SCW; Analyzed data: ZYZ; Interpreted results of experiments: QFG, ZYZ; Prepared figures: SCW; Drafted manuscript: SCW; Edited and revised manuscript: QFG; Approved final version of manuscript: QFG, SCW, ZYZ.

Corresponding author

Correspondence to Zeyan Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was conducted with approval of the Ethics Committee of Linyi People’s Hospital and in line with the Declaration of Helsinki. All patients and/or legal guardians signed the informed consent documentation prior to sample collection. Animal experiments were approved by the Animal Ethics Committee of Linyi People’s Hospital. Great efforts were made to minimize the number of animals used in the experiments and their suffering.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Q., Wang, S. & Zhang, Z. E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis. Gene Ther 30, 51–63 (2023). https://doi.org/10.1038/s41434-021-00289-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41434-021-00289-z

This article is cited by

Search

Advanced search

Quick links